Clinical Trial Update: Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of norketotifen for uncomplicated influenza-like illness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza-like Illness

Drugs mentioned

• Norketotifen (norketotifen)

Snippet

Sponsor: Emergo Therapeutics, Inc. | Conditions: Influenza, Influenza -Like Illness | Phase 2 | Status: COMPLETED